Dr. Josep Redón i Mas

Investigador Principal
Grupo de Estudio de Riesgo Cardiometabólico y Renal

Presentación

El Dr. Redón cursa sus estudios en la Facultad de Medicina de la Universitat de València (1974), doctorándose en esta Universidad en 1985. Desde 2006 es Catedrático de Medicina Interna de Facultad de Medicina de la Universitat de València y Jefe de Servicio de Medicina Interna del Hospital Clínico de Valencia desde 1995.

Su actividad investigadora se ha realizado en paralelo a su actividad clínica poniendo en práctica una investigación traslacional en el campo de la Hipertensión Arterial y Riesgo Cardiovascular. Investigador principal y participante en más de 40 proyectos competitivos nacionales e internacionales. Ha cursado un Fellowship in Hypertension en el Departamento de Nefrología e Hipertensión de la Northwestern University (Prof. D Batlle) en Chicago y cuenta con estancias en el Departamento de Epidemiología y Medicina Preventiva de la Loyola University.

Está muy involucrado con las principales Sociedades Científicas de Hipertensión nacionales e internacionales. Ha sido Presidente de la Sociedad Española de Hipertensión, Presidente y Officer at Large de la European Society of Hipertensión y Fellow del Council for High Blood Pressure, American Heart Association. Miembro de Honor de las Sociedades de Hipertensión de Portugal, Bulgaria, Rumanía, España y de la Sociedad Latino-Americana (LASH). Entre otros méritos, destaca su participación como evaluador de la  Agencia Nacional de Evaluación y Prospectiva (ANECA) de la Secretaría de Estado de Universidades.

Dentro de la actividad Editorial es Miembro del Editorial Board de revistas indexadas en el campo de hipertensión, editor asociado del Journal of Hypertension, revisor de revistas del campo cardiovascular y de Medicina Interna y autor de numerosas editoriales y artículos de revisión por invitación. Cuenta con 560 publicaciones en revistas Indexadas, un total de 52407 citas y un factor de impacto acumulado superior a 1.100.

Recientemente ha sido galardonado con el título de Doctor Honoris Causa por la Universidad Carol Davila, Bucarest, y ha recibido el Premio a la Excelencia Sanitaria del Instituto Europeo de Salud y Bienestar Social.

Investigador
Principal
Dr. Josep Redón i Mas

josep.redon@uv.es/jredon@uv.es

Publicaciones
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. Olea B, Albert E, Torres I, Amat P, Remigia M, Gozalbo-Rovira R, Rodriguez-Diaz J, Buesa J, Blasco M, Redon J, Signes-Costa J, Navarro D. Journal of Clinical Virology. 2021 Sep;142:104943. doi: 10.1016/j.jcv.2021.104943. PMID: 34391981

Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: the LipoLab Study.. Pallares-Carratala V, Quesada J, Orozco-Beltran D, Amigo-Grau N, Lopez-Pineda A, Fernandez Gimenez A, Gil-Guillen V, Correig X, Masana L, Monleon Salvado D, Redón Mas J, Pascual R, Carratala-Munuera C. International Journal of Clinical Practice. 2021 Jan;75(1):e13610. doi: 10.1111/ijcp.13610. PMID: 32648987

Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: a literature review. Piqueras P, Ballester A, Dura-Gil J, Martinez-Hervas S, Redon J, Real J. Frontiers in Psychology. 2021 Jul 9;12:631179. doi: 10.3389/fpsyg.2021.631179. PMID: 34305707

Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. Boehm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JF, Mahfoud F. Journal of Hypertension. 2021 Aug 1;39(8):1602-1610. doi: 10.1097/HJH.0000000000002822. PMID: 34188004

Cardiovascular system in the sars-CoV-2: impact of therapies. Redon J. Journal of Hypertension. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860. PMID: 34074967

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. Nunez-Gil I, Fernandez-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Munoz V, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas M, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejia A, Raposeiras-Roubin S, D’Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-Perez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Cardiology Journal. 2021 Feb 11;42(6):700-710. doi: 10.1093/eurheartj/ehaa943. PMID: 33351892

Genetic variation and urine cadmium levels: ABCC1 effects in the Strong Heart Family Study. Grau-Perez M, Voruganti V, Balakrishnan P, Haack K, Goessler W, Franceschini N, Redon J, Cole S, Navas-Acien A, Tellez-Plaza M. Environmental pollution. 2021 Feb 11;276:116717. doi: 10.1016/j.envpol.2021.116717. PMID: 33640655

Insights into glomerular filtration and albuminuria. Redon J, Selma-Soriano E, Cortes R. New England Journal of Medicine. 2021 Jul 29;385(5):477-478. doi: 10.1056/NEJMc2108129. PMID: 34320301

Rabphilin silencing causes dilated cardiomyopathy in a Drosophila model of nephrocyte damage. Selma-Soriano E, Casillas-Serra C, Artero R, Llamusi B, Navarro J, Redon J. Scientific Reports. 2021 Jul 27;11(1):15287. doi: 10.1038/s41598-021-94710-7. PMID: 34315987

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort. Ruiz-Quintero M, Redón Mas J, Tellez-Plaza M, Cebrian-Cuenca A, Navarro Perez J, Menendez E, Perez-Navarro A, Fernandez-Gimenez A, Lopez-Pineda A, Quesada J, Pallares-Carratala V, Gil-Guillen V, Martín Moreno J, Bleda-Cano J, Carrascosa S, Carratala-Munuera C. Primary Care Diabetes. 2021 Feb;15(1):88-94. doi: 10.1016/j.pcd.2020.06.004. PMID: 32646765

Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. Bohm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder R, Sliwa K, Lehrke M, Marx N, Weber M, Williams B, Yusuf S, Mann J. Journal of Hypertension. 2021 Feb 3. doi: 10.1097/HJH.0000000000002697. PMID: 33560052

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcaráz Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. PMID: 32579268

Small Rab GTPases in intracellular vesicle trafficking: the case of Rab3A/Raphillin-3a complex in the kidney. Martinez-Arroyo O, Selma-Soriano E, Ortega A, Cortes R, Redon J. International Journal of Molecular Sciences. 2021 Jul 18;22(14):7679. doi: 10.3390/ijms22147679. PMID: 34299299

Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Martinez-Arroyo O, Ortega A, Redon J, Cortes R. Hypertension. 2021 Jan;77(1):28-38. doi: 10.1161/HYPERTENSIONAHA.120.16064. PMID: 33222549

Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. Perez Hernandez J, Martínez Arroyo O, Ortega Gutiérrez A, Galera Martos M, Solis Salguero M, Chaves Martínez F, Redón Mas J, Forner Giner M, Cortés Vergaz R. Journal Of Nephrology. 2021 Aug;34(4):1157-1167. doi: 10.1007/s40620-020-00832-y. PMID: 32803682

Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Perez-Hernandez J, Riffo-Campos A, Ortega A, Martinez-Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, Cortes R. Hypertension. 2021 Mar 3;77(3):960-971. doi: 10.1161/HYPERTENSIONAHA.120.16598. PMID: 33486986

Acute kidney injury in heart failure: a population study. Holgado Sánchez J, Lopez Forte C, Fernández Giménez A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Nuñez Villota J, Redón Mas J, Ruiz Hernandez A. Esc Heart Failure. 2020 Apr;7(2):415-422. doi: 10.1002/ehf2.12595. PMID: 32059081

Arsenic, cadmium, and selenium exposures and bone mineral density-related endpoints: The Hortega study. Galvez-Fernandez M, Grau-Perez M, Garcia-Barrera T, Ramirez-Acosta S, Gomez-Ariza J, Perez-Gomez B, Galan-Labaca I, Navas-Acien A, Redon J, Briongos-Figuero L, Duenas-Laita A, Perez-Castrillon J, Tellez-Plaza M, Martin-Escudero J. Free Radical Biology & Medicine. 2020 Oct 30;S0891-5849(20)31592-6. doi: 10.1016/j.freeradbiomed.2020.10.318. PMID: 33137469

Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease. Pichler G, Redon J, Martinez F, Solaz E, Calaforra O, Andres M, Lopez B, Diez J, Oberbauer R, Adlbrecht C, Karth G, Maceira A. Journal of Hypertension. 2020 Oct;38(10):2036-2042. doi: 10.1097/HJH.0000000000002504. PMID: 32890280

Chronic kidney disease as a cardiovascular risk factor. Carmena Rodriguez R, Ascaso Gimilio J, Redón Mas J. Journal of Hypertension. 2020 Nov;38(11):2110-2121. doi: 10.1097/HJH.0000000000002506. PMID: 32649622

Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia. Blasco Cortes M, Buesa Gomez J, Colomina Rodríguez F, Forner Giner M, Galindo Puerto M, Navarro Perez J, Noceda Bermejo J, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal Of Medical Virology. 2020 Oct;92(10):1799-1801. doi: 10.1002/jmv.25922. PMID: 32320082

Decreased Urinary Levels of SIRT1 as Non-Invasive Biomarker of Early Renal Damage in Hypertension. Martínez Arroyo O, Ortega Gutiérrez A, Galera Martos M, Solaz Moreno E, Martinez Hervas S, Redón Mas J, Cortés Vergaz R. International Journal of Molecular Sciences. 2020 Sep 2;21(17):6390. doi: 10.3390/ijms21176390. PMID: 32887498

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. NCD Risk Factor Collaboration. Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6. PMID: 33160572

Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Borghi C, Agabiti-Rosei E, Johnson R, Kielstein J, Lurbe Ferrer E, Mancia G, Redón Mas J, Stack A, Tsioufis K. European Journal of Internal Medicine. 2020 Oct;80:1-11. doi: 10.1016/j.ejim.2020.07.006. PMID: 32739239

Identifying poor cardiorespiratory fitness in overweight and obese children and adolescents by using heart rate variability analysis under resting conditions. Redon Lurbe P, Grassi G, Redón Mas J, Alvarez Pitti J, Lurbe Ferrer E. Blood Pressure. 2020 Feb;29(1):13-20. doi: 10.1080/08037051.2019.1700777. PMID: 31829032

Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population Study. López Zumel M, Holgado Sánchez J, Ferrandez Izquierdo A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Bea Serrano C, Nuñez Villota J, Ferrer Albero A, Gamez Payá J, Ruiz Hernandez A, Redón Mas J. Journal of Clinical Medicine. 2020 Jun 15;9(6):1869. doi: 10.3390/jcm9061869. PMID: 32549339

National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries. NCD Risk Factor Collaboration. International Journal of Epidemiology. 2020 Feb 1;49(1):173-192. doi: 10.1093/ije/dyz099. PMID: 31321439

Nutraceuticals and blood pressure control: a European Society of Hypertension position document. Borghi C, Tsioufis K, Agabiti-Rosei E, Burnier M, Cicero A, Clement D, Coca A, Desideri G, Grassi G, Lovic D, LURBE FERRER E, Kahan T, Kreutz R, Jelakovic B, Polonia J, Redón Mas J, Van De Borne P, Mancia G. Journal of Hypertension. 2020 May;38(5):799-812. doi: 10.1097/HJH.0000000000002353. PMID: 31977574

Optimization of small RNA library preparation protocol from human urinary exosomes. Olivares Gazquez M, Perez Hernandez J, Perez Gil D, Chaves Martínez F, Redón Mas J, Cortés Vergaz R. Journal of Translational Medicine. 2020 Mar 18;18(1):132. doi: 10.1186/s12967-020-02298-9. PMID: 32188466

Pulmonary thrombosis in situ’: risk factors, clinic characteristics and long-term evolution. Fletcher-Sanfeliu D, Redon J, Garcia-Granero A, Frasson M, Barreira I, Martinez-Leon J, Garcia-Fuster M. Blood Coagulation & Fibrinolysis. 2020 Oct;31(7):469-475. doi: 10.1097/MBC.0000000000000949. PMID: 32833808

Rab-rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II. Martínez Arroyo O, Ortega Gutiérrez A, Perez Hernandez J, Chaves Martínez F, Redón Mas J, Cortés Vergaz R. American Journal of Physiology. Renal Physiology. 2020 Aug 1;319(2):F178-F191. doi: 10.1152/ajprenal.00077.2020. PMID: 32567349

Rabphilin involvement in filtration and molecular uptake in Drosophila nephrocytes suggests a similar role in human podocytes. Selma Soriano E, Llamusi Troisi M, Fernandez Costa J, Ozimski L, Artero Allepuz R, Redón Mas J. Disease Models & Mechanisms. 2020 Sep 21;13(9):dmm041509. doi: 10.1242/dmm.041509. PMID: 32680845

Redefining hypertension in children and adolescents: A review of the evidence considered by the European Society of Hypertension and American Academy of Pediatrics guidelines.Stabouli S, Redón Mas J, Lurbe Ferrer E. Journal of Hypertension. 2020 Feb;38(2):196-200. doi: 10.1097/HJH.0000000000002247. PMID: 31584513

Repositioning of the global epicentre of non-optimal cholesterol. NCD Risk Factor Collaboration (NCD-RisC). Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. PMID: 32494083

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.Böhm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Ukena C, Mann J, Mancia G, Redón Mas J, Schmieder R, Sliwa K, Marx N, Weber M, Williams B, Yusuf S. European Heart Journal. 2020 Jan 7;41(2):231-238. doi: 10.1093/eurheartj/ehy808. PMID: 30590564

The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study. Orozco-Beltran D, Navarro Perez J, Cebrian-Cuenca A, Alvarez-Guisasola F, Caride-Miana E, Mora G, Quesada J, Lopez-Pineda A, Cardona-Llorens A, Redón Mas J, Gil-Guillen V, Ferrandez Izquierdo A, Carratala-Munuera C. Primary Care Diabetes. 2020 Dec;14(6):678-684. doi: 10.1016/j.pcd.2020.06.003. PMID: 32605878

Unraveling new factors associated with hypertension: the Mendelian randomization approach. Grau Pérez M, Redón Mas J. Journal of Hypertension. 2020 Jan;38(1):30-32. doi: 10.1097/HJH.0000000000002251. PMID: 31790017

Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Piepoli M, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano A, Corra U, Cosyns B, Deaton C, Graham I, Hoes A, Lochen M, Matrone B, Redón Mas J, Sattar N, Smulders Y, Tiberi M. European Journal of Preventive Cardiology. 2020 Jan;27(2):181-205. doi: 10.1177/2047487319893035. PMID: 31826679

Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. Mancia G, Schumacher H, Bohm M, Mann J, Redón Mas J, Facchetti R, Schmieder R, Lonn E, Teo K, Yusuf S. Journal of Hypertension. 2020 Oct;38(10):2050-2058. doi: 10.1097/HJH.0000000000002567. PMID: 32694337

2018 ESC/ESH Guidelines for the management of arterial. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. Kardiologia Polska. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. PMID: 30816983

Association of Arsenic Exposure With Cardiac Geometry and Left Ventricular Function in Young Adults. Pichler G, Grau-Perez M, Tellez-Plaza M, Umans J, Best L, Cole S, Goessler W, Francesconi K, Newman J, Redon J, Devereux R, Navas-Acien A. Circulation. Cardiovascular imaging. 2019 May;12(5):e009018. doi: 10.1161/CIRCIMAGING.119.009018. PMID: 31060373

Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S. European Heart Journal. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149. PMID: 30919899

Cohort profile: the Hortega Study for the evaluation of non-traditional risk factors of cardiometabolic and other chronic diseases in a general population from Spain. Tellez-Plaza M, Briongos-Figuero L, Pichler G2, Dominguez-Lucas A, Simal-Blanco F, Mena-Martin FJ, Bellido-Casado J, Arzua-Mouronte D, Chaves FJ, Redon J, Martin-Escudero JC. BMJ Open. 2019 Jun 27;9(6):e024073. doi: 10.1136/bmjopen-2018-024073. PMID: 31248913

Diastolic left ventricular function in relation to circulating metabolic biomarkers in a population study. Zhang ZY, Marrachelli VG, Yang WY, Trenson S, Huang QF, Wei FF, Thijs L, Van Keer J, Monleon D, Verhamme P, Voigt JU, Kuznetsova T, Redón J, Staessen JA. European Journal of Preventive Cardiology. 2019 Jan;26(1):22-32. doi: 10.1177/2047487318797395. PMID: 30196724

Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study. Redon P, Maloberti A, Facchetti R, Redon J, Lurbe E, Bombelli M, Mancia G, Grassi G. Journal of Hypertension. 2019 Feb;37(2):380-388. doi: 10.1097/HJH.0000000000001908. PMID: 30074564

Immigration and hypertension in youths learning from one country’s experience. Lurbe E, Redon J. Journal of Hypertension. 2019 Apr;37(4):680-682. doi: 10.1097/HJH.0000000000002028. PMID: 30817446

Immune-unreactive urinary albumin as a predictor of cardiovascular events: the Hortega Study. Martínez F, Pichler G, Ruiz A, Martín-Escudero JC, Chaves FJ, Gonzalez-Albert V, Tellez-Plaza M, Heerspink HJL, Zeeuw DDE, Redon J. Nephrology Dialysis Transplantation. 2019 Apr 1;34(4):633-641. doi: 10.1093/ndt/gfy087. PMID: 29788140

Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. Lurbe E, Torró I, Álvarez J, Aguilar F, Mancia G, Redon J, Redon P. Journal of Hypertension. 2019 Dec;37(12):2414-2421. doi: 10.1097/HJH.0000000000002229. PMID: 31688292

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain. Redón J, Usó R, Trillo JL, López C, Morales-Olivas F, Navarro J, Sanchís J, Gil V, Orozco-Beltrán D. International Journal of Cardiology. 2019 Oct 15;293:260-265. doi: 10.1016/j.ijcard.2019.05.071. PMID: 31229263

Rising rural body-mass index is the main driver of the global obesity epidemic in adults. NCD Risk Factor Collaboration (NCD-RisC). Nature. 2019 May;569(7755):260-264. doi: 10.1038/s41586-019-1171-x. PMID: 31068725

The association of urine metals and metal mixtures with cardiovascular incidence in an adult population from Spain: the Hortega Follow-Up Study. Domingo-Relloso A, Grau-Perez M, Briongos-Figuero L, Gomez-Ariza JL, Garcia-Barrera T, Dueñas-Laita A, Bobb JF, Chaves FJ, Kioumourtzoglou MA, Navas-Acien A, Redon-Mas J, Martin-Escudero JC, Tellez-Plaza M. International Journal of Epidemiology. 2019 Dec 1;48(6):1839-1849. doi: 10.1093/ije/dyz061. PMID: 31329884

Urinary metals and metal mixtures and oxidative stress biomarkers in an adult population from Spain: The Hortega Study. Domingo-Relloso A, Grau-Perez M, Galan-Chilet I, Garrido-Martinez MJ, Tormos C, Navas-Acien A, Gomez-Ariza JL, Monzo-Beltran L, Saez-Tormo G, Garcia-Barrera T, Dueñas Laita A, Briongos Figuero LS, Martin-Escudero JC, Chaves FJ, Redon J, Tellez-Plaza M. Environment International. 2019 Feb;123:171-180. doi: 10.1016/j.envint.2018.11.055. PMID: 30529889

Proyectos
Referencia: WELLBASED
Título: WELLBASED. Improving health, wellbeing and equality by evidenced-based urban policies for tackling energy poverty
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2021 – 2024
Presupuesto:

Referencia: PI19/01796
Título: Implicaciones experimentales y clinicas del complejo proteico rabphilin-rab en daño renal en la diabetes mellitus tipo 2
Entidad Financiadora: Instituto de Salud Carlos III
Investigador principal: Josep Redón i Mas
Duración: 2020 – 2022
Presupuesto: 196.020 €

Referencia: BigMedilytics
Título: Big Data for Medical Analytics
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2021
Presupuesto: 1062136,25

Referencia: BodyPass
Título: API-ecosystem for cross-sectorial exchange of 3D personal data
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2020
Presupuesto: 351937,5

Referencia: PT17/0005/0017
Título: Innovation Platform
Entidad Financiadora: Instituto de Salud Carlos III
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2021
Presupuesto: 38.985 €

Referencia: BigData@Heart
Título: Big Data for Better Hearts
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2017 – 2022
Presupuesto: 386250

Referencia: PI16/01402
Título: Estudio experimental in vivo e in vitro y la aplicación clínica del impacto de las proteínas del complejo Rhabphilin-Rab en el desarrollo del daño renal y cardiovascular
Entidad Financiadora: Instituto de Salud Carlos III
Investigador principal: Josep Redón i Mas
Duración: 2017 – 2019
Presupuesto: 194.205 €

Referencia: PROMETEO/2016/084
Título: tisular
Entidad Financiadora: Conselleria de Educación Cultura y Deporte
Investigador principal: Josep Redón i Mas
Duración: 2016 – 2019
Presupuesto: 246.190 €

Referencia: ADVANTAGE
Título: Managing Frailty. A comprehensive approach to promote a disability-free advanced age in Europe: the ADVANTAGE initiative
Entidad Financiadora: European Commission (3rd Health Program)
Investigador principal: Josep Redón i Mas, José Viña Ribes
Duración: 2016 – 2020
Presupuesto: 130005

+ Información
2018 ESC/ESH Guidelines for the management of arterial. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. Kardiologia Polska. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. PMID: 30816983

Redefining hypertension in children and adolescents: A review of the evidence considered by the European Society of Hypertension and American Academy of Pediatrics guidelines.Stabouli S, Redón Mas J, Lurbe Ferrer E. Journal of Hypertension. 2020 Feb;38(2):196-200. doi: 10.1097/HJH.0000000000002247. PMID: 31584513

Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. Lurbe E, Torró I, Álvarez J, Aguilar F, Mancia G, Redon J, Redon P. Journal of Hypertension. 2019 Dec;37(12):2414-2421. doi: 10.1097/HJH.0000000000002229. PMID: 31688292

Título: Estudio de la evolución del sellado distal ilíaco en el tratamiento endovascular de la aorta abdominal
Doctorando: Bargay Juan, Pau
Director: Redon Mas, Josep; Plaza Martínez, Ángel
Fecha: 25/02/2019
Universidad: Universitat de València

Título: Sistema de biosensado fotónico para la detección de trombina, alérgenos y patógenos. Funcionalización química de chips fotónicos basados en estructuras de anillos resonantes
Doctorando: Sánchez Sánchez, Carlos
Director: Martí Sendra, Javier; Redón Mas, Josep; Peransí Llopis, Sergio Manuel
Fecha: 15/11/2019
Universidad: Universitat Politècnica de València

Título: Valor pronóstico de los cambios en la rigidez arterial en la hipertensión arterial esencial
Doctorando: Calaforra Juan, Oscar
Director: Redón Mas, Josep; Forner Giner, María José; Martínez García, Fernando
Fecha: 28/07/2020
Universidad: Universitat de València